首頁 > 市場調查報告書 > 製藥

疫苗癌症

市場調查報告書

商品編碼

1820525

全球癌症疫苗市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及預測（2025 年至 2033 年）

Global Cancer Vaccines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年08月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球癌症疫苗市場預計將大幅成長，預計市場規模將從 2024 年的 95.9 億美元飆升至 2033 年的 249.5 億美元，預測期內年複合成長率(CAGR) 高達 11.21%。

隨著免疫療法在腫瘤治療模式中日益凸顯，癌症疫苗市場正在快速發展。癌症疫苗旨在刺激免疫系統識別並攻擊腫瘤細胞，包括針對子宮頸癌、前列腺癌和黑色素瘤等多種癌症的預防性和治療性疫苗。包括肽基疫苗、樹突細胞疫苗和mRNA疫苗在內的疫苗平台的創新正在提升疫苗的特異性、有效性和安全性。

癌症疫苗與檢查點抑制劑和個人化醫療方法的結合正在拓展臨床應用。生物標記識別和基因組分析的進步支持患者分層和疫苗客製化。監管部門的批准和臨床試驗的成功正在加速市場成長。此外，癌症發生率和認知度的提高也推動了對新型免疫療法的需求。

生物技術公司、研究機構和醫療保健提供者之間的合作正在促進創新和商業化。隨著免疫腫瘤學的發展，癌症疫苗市場有望顯著成長，為改善患者預後提供有前景的治療選擇。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概況：對市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新和潛在投資領域。本部分提供對未來市場發展和成長前景的洞察。

涵蓋的細分市場列表

癌症疫苗市場報告的此部分提供了國家和地區層面的細分詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按疫苗類型

預防癌症疫苗
治療性癌症疫苗
其他

依適應症類型

攝護腺癌
膀胱癌
黑色素瘤
子宮頸癌
其他

依技術類型

重組癌症疫苗
全細胞癌症疫苗
病毒載體和DNA癌症疫苗
其他技術
報告中介紹的公司列表
默克公司、葛蘭素史克公司、Dendreon Pharmaceuticals LLC、Dynavax Technologies Corporation、Ferring BV、安進、Moderna Inc.、賽諾菲、阿斯特捷利康、百時美施貴寶。

如果您有任何客製化需求，請聯絡我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第9章：癌症疫苗公司的競爭格局

癌症疫苗市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第10章：公司簡介

頂級公司市佔率分析
市場集中度
Merck & Co. Inc.

公司概況
公司收入
產品
最新動態

GSK Plc

公司概況
公司收入
產品
最新動態

Dendreon Pharmaceuticals LLC

公司概況
公司收入
產品
最新動態

Dynavax Technologies Corporation

公司概況
公司收入
產品
最新動態

Ferring BV

公司概況
公司收入
產品
最新動態

Amgen Inc.

公司概況
公司收入
產品
最新動態

Moderna Inc.

公司概況
公司收入
產品
最新動態

Sanofi

公司概況
公司收入
產品
最新動態

AstraZeneca

公司概況
公司收入
產品
最新動態

Bristol Myers Squibb

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，或者在私人公司的情況下可能不涵蓋

簡介目錄圖表

Product Code: VMR112116893

Global Cancer Vaccines Market is poised for a significant growth, with market size projected to surge from USD 9.59 Billion in 2024 to USD 24.95 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 11.21% during the forecast period.

The cancer vaccines market is advancing rapidly as immunotherapy gains prominence in oncology treatment paradigms. Cancer vaccines, designed to stimulate the immune system to recognize and attack tumor cells, include prophylactic and therapeutic types targeting various cancers such as cervical, prostate, and melanoma. Innovations in vaccine platforms, including peptide-based, dendritic cell, and mRNA vaccines, are enhancing specificity, efficacy, and safety profiles.

The integration of cancer vaccines with checkpoint inhibitors and personalized medicine approaches is expanding clinical applications. Advances in biomarker identification and genomic profiling support patient stratification and vaccine customization. Regulatory approvals and clinical trial successes are accelerating market growth. Additionally, increasing cancer incidence and awareness are driving demand for novel immunotherapies.

Collaborations among biotech firms, research institutions, and healthcare providers are fostering innovation and commercialization. As immuno-oncology evolves, the cancer vaccines market is positioned for significant growth, offering promising therapeutic options to improve patient outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Cancer Vaccines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Vaccine Type

Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Others

By Indication Type

Prostate Cancer
Bladder Cancer
Melanoma
Cervical Cancer
Other

By Technology Type

Recombinant Cancer Vaccines
Whole-cell Cancer Vaccines
Viral Vector and DNA Cancer Vaccines
Other Technologies
List of Companies Profiled in the report
Merck & Co. Inc., GSK plc, Dendreon Pharmaceuticals LLC, Dynavax Technologies Corporation, Ferring B.V., Amgen Inc., Moderna Inc., Sanofi, AstraZeneca, Bristol Myers Squibb.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. CANCER VACCINES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Vaccine Type
- 3.7.2 Market Attractiveness Analysis By Indication Type
- 3.7.3 Market Attractiveness Analysis By Technology Type
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL CANCER VACCINES MARKET ANALYSIS BY VACCINE TYPE

5.1. Overview By Vaccine Type
5.2. Historical and Forecast Data Analysis By Vaccine Type
5.3. Preventive Cancer Vaccines Historic and Forecast Sales By Regions
5.4. Therapeutic Cancer Vaccines Historic and Forecast Sales By Regions
5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL CANCER VACCINES MARKET ANALYSIS BY INDICATION TYPE

6.1. Overview By Indication Type
6.2. Historical and Forecast Data Analysis By Indication Type
6.3. Prostate Cancer Historic and Forecast Sales By Regions
6.4. Bladder Cancer Historic and Forecast Sales By Regions
6.5. Melanoma Historic and Forecast Sales By Regions
6.6. Cervical Cancer Historic and Forecast Sales By Regions
6.7. Other Historic and Forecast Sales By Regions

7. GLOBAL CANCER VACCINES MARKET ANALYSIS BY TECHNOLOGY TYPE

7.1. Overview By Technology Type
7.2. Historical and Forecast Data Analysis By Technology Type
7.3. Recombinant Cancer Vaccines Historic and Forecast Sales By Regions
7.4. Whole-cell Cancer Vaccines Historic and Forecast Sales By Regions
7.5. Viral Vector and DNA Cancer Vaccines Historic and Forecast Sales By Regions
7.6. Other Technologies Historic and Forecast Sales By Regions

8. GLOBAL CANCER VACCINES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CANCER VACCINES COMPANIES

9.1. Cancer Vaccines Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF CANCER VACCINES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Merck & Co. Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. GSK Plc
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Dendreon Pharmaceuticals LLC
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Dynavax Technologies Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Ferring B.V.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Amgen Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Moderna Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Sanofi
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. AstraZeneca
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Bristol Myers Squibb
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments